Attached files
| file | filename |
|---|---|
| EX-32.3 - HEMACARE CORP /CA/ | ex32-1.htm |
| 10-K - HEMACARE CORPORATION - HEMACARE CORP /CA/ | eps3753.htm |
| EX-21 - HEMACARE CORP /CA/ | ex21.htm |
| EX-23.1 - HEMACARE CORP /CA/ | ex23-1.htm |
| EX-31.2 - HEMACARE CORP /CA/ | ex31-2.htm |
| EX-31.1 - HEMACARE CORP /CA/ | ex31-1.htm |
Exhibit 11
HemaCare Corporation
Basic and Diluted Net Income per Share
|
Years ended December 31,
|
||||||||
|
2009
|
2008
|
|||||||
|
BASIC
|
||||||||
|
Weighted average common shares used to compute basic earnings per share
|
10,008,000 | 9,533,000 | ||||||
|
Net income - continuing operations
|
$ | 905,000 | $ | 899,000 | ||||
|
Basic net income per share - continuing operations
|
$ | 0.09 | $ | 0.09 | ||||
|
Net (loss) income - discontinued operations
|
$ | (50,000 | ) | $ | 80,000 | |||
|
Basic net income per share - discontinued operations
|
$ | - | $ | 0.01 | ||||
|
Total net income
|
$ | 855,000 | $ | 979,000 | ||||
|
Total basic net income per share
|
$ | 0.09 | $ | 0.10 | ||||
|
DILUTED
|
||||||||
|
Weighted average common shares used to compute basic earnings per share
|
10,008,000 | 9,533,000 | ||||||
|
Dilutive common equivalent shares attributable to stock options (based on average market price)
|
124,000 | 173,000 | ||||||
|
Weighted average common shares and equivalents used to compute diluted earnings per share
|
10,132,000 | 9,706,000 | ||||||
|
Net income - continuing operations
|
$ | 905,000 | $ | 899,000 | ||||
|
Diluted net income per share - continuing operations
|
$ | 0.09 | $ | 0.09 | ||||
|
Net (loss) income - discontinued operations
|
$ | (50,000 | ) | $ | 80,000 | |||
|
Diluted net income per share -discontinued operations
|
$ | - | $ | 0.01 | ||||
|
Total net income
|
$ | 855,000 | $ | 979,000 | ||||
|
Total diluted net income per share
|
$ | 0.08 | $ | 0.10 | ||||